Friday, July 13, 2007

Pathogenesis of Malignant Mesothelioma

About 80% of malignant mesotheliomas in the Western World develop in individuals with higher than background exposure to asbestos. Only a fraction of those exposed to asbestos develop mesothelioma, indicating that additional factors play a role. Simian virus 40 (SV40), a DNA tumor virus that preferentially causes mesothelioma in hamsters, has been detected in several human mesotheliomas.
The expression of the SV40 large tumor antigen in mesothelioma cells, and not in nearby stromal cells, and the capacity of antisense T-antigen treatment to arrest mesothelioma cell growth in vitro suggest that SV40 contributes to tumor development. The capacity of T-antigen to bind and inhibit cellular p53 and retinoblastoma (Rb)-family proteins in mesothelioma, together with the very high susceptibility of human mesothelial cells to SV40-mediated transformation in vitro, supports a causative role of SV40 in the pathogenesis of mesothelioma.
Asbestos appears to increase SV40-mediated transformation of human mesothelial cells in vitro, suggesting that asbestos and SV40 may be cocarcinogens. p53 mutations are rarely found in mesothelioma; p16, p14ARF, and NF2 mutations/losses are frequent.
Recent studies revealed the existence of a genetic factor that predisposes affected individuals to mesothelioma in the villages of Karain and Tuzkoy, in Anatolia, Turkey. Erionite, a type of zeolite, may be a cofactor in these same villages, where 50% of deaths are caused by mesothelioma.

Mesothelioma appears to have a complex etiology in which environmental carcinogens (asbestos and erionite), ionizing radiation, viruses, and genetic factors act alone or in concert to cause malignancy. Copyright 2002 by W.B. Saunders Company.

Saturday, June 23, 2007

Care for Mesothelioma Patients

Mesothelioma cancer is one such disease that can happen to anyone both you and me. But records state the major victims come from the worker class of the asbestos companies, shipping companies and construction yards including mines where asbestos is one of the major minerals dealt with. This is primarily a lung disorder that ultimately takes the shape of fatal cancer.

Caring a Mesothelioma patient is very tough. Caring here doesn't simply mean physical care. A Mesothelioma patient has to be given equal mental and emotional support to fight with the situation. Most of the time it has been observed that the patient completely loses faith in life.

Proper knowledge and guidance

Especially the near and dear ones of the patients must have adequate knowledge about the disease and also know what type of support should be given to the patient. There are doctors to look into the case but they are not available always. It is you who will be by the side of patient in his/her needs.

Treat the patient humbly and give him medicines and food at the right hour. The pain along the chest side is sometimes acute and unbearable. You must have an S.O.S. for instant relief. For Mesothelioma patients, morphine is a very good remedy. But a misconception prevails with the use of morphine and most of us refer it to be a sedative drug with other adverse side effects. Such preconceived notions have to be taken out of mind. Both the patient and the patient's relatives should have a positive mind setup and follow the doctor's prescription in an accurate manner. Otherwise you will welcome further troubles.

Well it is known to all of us that the Mesothelioma patient won't be able to sustain life with this cancer inside the body. But they too have every right to enjoy life till they close their eyes forever. Give them hope and happiness so that they live their life to the fullest even in this short time period. Let depression and despair not make shelter in their minds to blemish the rest of the days they are alive.

About the Author
Find more Mesothelioma and asbestos info online. For Credit repair related articles: http://www.credit-repair-fyi.info

Friday, June 1, 2007

Beta Carotene and Vitamin A on Lung Cancer

Lung cancer and cardiovascular disease are major causes of death in the United States. It has been proposed that carotenoids and retinoids are agents that may prevent these disorders.

We conducted a multicenter, randomized, double-blind, placebo-controlled primary prevention trial — the Beta-Carotene and Retinol Efficacy Trial — involving a total of 18,314 smokers, former smokers, and workers exposed to asbestos. The effects of a combination of 30 mg of beta carotene per day and 25,000 IU of retinol (vitamin A) in the form of retinyl palmitate per day on the primary end point, the incidence of lung cancer, were compared with those of placebo.

A total of 388 new cases of lung cancer were diagnosed during the 73,135 person-years of follow-up (mean length of follow-up, 4.0 years). The active-treatment group had a relative risk of lung cancer of 1.28 (95 percent confidence interval, 1.04 to 1.57; P = 0.02), as compared with the placebo group. There were no statistically significant differences in the risks of other types of cancer. In the active-treatment group, the relative risk of death from any cause was 1.17 (95 percent confidence interval, 1.03 to 1.33); of death from lung cancer, 1.46 (95 percent confidence interval, 1.07 to 2.00); and of death from cardiovascular disease, 1.26 (95 percent confidence interval, 0.99 to 1.61). On the basis of these findings, the randomized trial was stopped 21 months earlier than planned; follow-up will continue for another 5 years.

After an average of four years of supplementation, the combination of beta carotene and vitamin A had no benefit and may have had an adverse effect on the incidence of lung cancer and on the risk of death from lung cancer, cardiovascular disease, and any cause in smokers and workers exposed to asbestos.

Saturday, May 12, 2007

Controversial Asbestos Settlement Heads to Court

After more than a year of bitter legal jockeying, an attempt to begin breaking the nation's biggest courthouse logjam - lawsuits surrounding asbestos - faces a critical test on courtroom. The case is complicated by any standard: millions of potential plaintiffs, dozens of lawyers, 20 defendants and more than two decades of wrangling over damages for people suffering from asbestos exposure.

The proposal to pay an estimated 100,000 asbestos-related disease sufferers or their families about $ 1 billion over the next 10 years is even more complex with stiff opposition and allegations of misconduct.

Backers and detractors will state their positions in a fairness hearing here Tuesday before U.S. District Judge Lowell Reed.

Lawyers who negotiated the deal call it a model for a faster and better way to compensate asbestos disease victims whose needs have gone unmet in court. Opponents call it inadequate and the result of collusion between the Center for Claims Resolution, a group of 20 former asbestos makers, and two law firms: Greitzer & Locks of Philadelphia and Ness, Motley, Loadholt, Richardson & Poole of Charleston, S.C.

Under the deal, consideration for damages would be given to anyone who requests it, a vastly simpler arrangement than hiring an attorney and waiting years for a case to wind its way through the justice system, said John Aldock, a lawyer for the Center for Claims Resolution.

A nationwide asbestos resolution has proven elusive. More than 100,000 cases are lined up in state and federal courts. The litigation has cost U.S. companies an estimated $ 7 billion, some $ 4 billion of it going to lawyers.

Under the settlement, average payments range from $ 5,800 for non-malignant disorders, such as labored breathing, to $ 60,000 for mesothelioma, a terminal lung cancer. The amounts are based on historical averages, proponents said, with the neediest paid first.

Only those showing symptoms get money. Victims could request additional compensation if they develop more serious illnesses. The CCR doesn't include the biggest asbestos manufacturers, and settlement plaintiffs still could sue them.

Critics argue that in most cases plaintiffs will receive a fifth of what they could win in court. Because of docket gridlock, however, most states are hearing cases filed in the late 1980s. All federal lawsuits have been on hold since 1992.

Wages, the union leader, figures that 350,000 to 400,000 of his current and former union members were exposed to potentially deadly amounts of asbestos. Many, including himself, will not be covered by the settlement because they weren't exposed for long enough periods - at least 10 years for mesothelioma and 12 years for other ailments.

Overall, more than 27 million Americans are estimated to have job-related exposure to asbestos, a natural insulator used for decades in construction, and roughly 1 million targeted by cancer. Not all of those people were exposed to products made by the companies included in the CCR, however.

There also have been questions about whether people who don't want to join the settlement "class" were adequately informed. People who wanted to be excluded, remaining free to sue CCR companies, had to inform the court by Jan. 24.

The settlement, filed in January 1993, received preliminary approval in October by Judge Reed, who ruled that accusations of collusion between the two firms and the CCR were unfounded.

Philadelphia lawyer Ben Shein said the law firms didn't do enough to determine whether defendants could afford to pay without a settlement. The National Asbestos Victims Legal Action Organizing Committee estimates the CCR members have $ 53.6 billion in assets.

But backers said draining company assets has driven 17 former asbestos manufacturers into bankruptcy. Locks said the settlement requires insurers to pay when necessary, helping guarantee defendants solvency as cases mount.

About the Author
For the latest asbestosis information, including case studies, treatment, diagnosis and symptoms, see: Mesothelioma Info.

Tuesday, May 8, 2007

Controversial Asbestos Settlement Heads to Court

After more than a year of bitter legal jockeying, an attempt to begin breaking the nation's biggest courthouse logjam - lawsuits surrounding asbestos - faces a critical test on courtroom. The case is complicated by any standard: millions of potential plaintiffs, dozens of lawyers, 20 defendants and more than two decades of wrangling over damages for people suffering from asbestos exposure.

The proposal to pay an estimated 100,000 asbestos-related disease sufferers or their families about $ 1 billion over the next 10 years is even more complex with stiff opposition and allegations of misconduct.

Backers and detractors will state their positions in a fairness hearing here Tuesday before U.S. District Judge Lowell Reed.

Lawyers who negotiated the deal call it a model for a faster and better way to compensate asbestos disease victims whose needs have gone unmet in court. Opponents call it inadequate and the result of collusion between the Center for Claims Resolution, a group of 20 former asbestos makers, and two law firms: Greitzer & Locks of Philadelphia and Ness, Motley, Loadholt, Richardson & Poole of Charleston, S.C.

Under the deal, consideration for damages would be given to anyone who requests it, a vastly simpler arrangement than hiring an attorney and waiting years for a case to wind its way through the justice system, said John Aldock, a lawyer for the Center for Claims Resolution.

A nationwide asbestos resolution has proven elusive. More than 100,000 cases are lined up in state and federal courts. The litigation has cost U.S. companies an estimated $ 7 billion, some $ 4 billion of it going to lawyers.

Under the settlement, average payments range from $ 5,800 for non-malignant disorders, such as labored breathing, to $ 60,000 for mesothelioma, a terminal lung cancer. The amounts are based on historical averages, proponents said, with the neediest paid first.

Only those showing symptoms get money. Victims could request additional compensation if they develop more serious illnesses. The CCR doesn't include the biggest asbestos manufacturers, and settlement plaintiffs still could sue them.

Critics argue that in most cases plaintiffs will receive a fifth of what they could win in court. Because of docket gridlock, however, most states are hearing cases filed in the late 1980s. All federal lawsuits have been on hold since 1992.

Wages, the union leader, figures that 350,000 to 400,000 of his current and former union members were exposed to potentially deadly amounts of asbestos. Many, including himself, will not be covered by the settlement because they weren't exposed for long enough periods - at least 10 years for mesothelioma and 12 years for other ailments.

Overall, more than 27 million Americans are estimated to have job-related exposure to asbestos, a natural insulator used for decades in construction, and roughly 1 million targeted by cancer. Not all of those people were exposed to products made by the companies included in the CCR, however.

There also have been questions about whether people who don't want to join the settlement "class" were adequately informed. People who wanted to be excluded, remaining free to sue CCR companies, had to inform the court by Jan. 24.

The settlement, filed in January 1993, received preliminary approval in October by Judge Reed, who ruled that accusations of collusion between the two firms and the CCR were unfounded.

Philadelphia lawyer Ben Shein said the law firms didn't do enough to determine whether defendants could afford to pay without a settlement. The National Asbestos Victims Legal Action Organizing Committee estimates the CCR members have $ 53.6 billion in assets.

But backers said draining company assets has driven 17 former asbestos manufacturers into bankruptcy. Locks said the settlement requires insurers to pay when necessary, helping guarantee defendants solvency as cases mount.

About the Author
For the latest asbestosis information, including case studies, treatment, diagnosis and symptoms, see: Mesothelioma Info.

Wednesday, May 2, 2007

Asbestos: Still a Carcinogen

Asbestos is an important cause of human illness. Clinical and epidemiologic studies have established incontrovertibly that asbestos causes cancer of the lung, malignant mesothelioma of the pleura and peritoneum, cancer of the larynx, and certain gastrointestinal cancers. Asbestos also causes asbestosis, a progressive fibrotic disease of the lungs. The risk of these diseases increases with cumulative exposure and also with the length of time since the first exposure

Asbestos is a generic term applied to a group of minerals, all of them fibrous. There are four commercially important forms: chrysotile, crocidolite, amosite, and anthophyllite. Chrysotile is the most important. It accounts for more than 95 percent of current world production. Nearly all asbestos used in North America has been chrysotile from the province of Quebec, Canada

All forms of asbestos are carcinogenic. All have been shown in clinical, epidemiologic, and laboratory studies to be fully capable of causing lung cancer, mesothelioma, and the full range of asbestos-related diseases. Although crocidolite appears to be two to four times more potent than chrysotile or amosite in its capacity to induce mesothelioma, all forms appear to be equally potent in their capacity to cause cancer of the lung.

New use of asbestos has almost completely ended in the United States and in most other developed nations as the result of government bans and market pressures. Those forces were stimulated by the landmark epidemiologic studies of Selikoff and colleagues6 and by the release of information on the carcinogenicity of asbestos that had previously been suppressed by the industry.7 By contrast, extensive and aggressive marketing of asbestos by Canada and other exporting nations continues in the developing world, where sales remain strong.

Monday, December 11, 2006

The Viciousness of Lung Cancer

Understanding The Viciousness of Lung Cancer by David Silva

Lung cancer is the result of malignant cells forming in the tissues of the lung, usually in the cells lining the air passages. The cells in our bodies are constantly dividing and reproducing. Usually, there's an orderly pattern to this reproduction as cells develop and specialize to meet particular needs. Occasionally, however, a cell becomes damaged. There's a mutation in its DNA, and rather than maturing and dying as is normal, it continues to reproduce unchecked. In essence, this is cancer - uncontrolled reproduction and growth of abnormal cells in the body.

Most lung cancers are believed to start in the epithelial lining of the lungs - the linings of the large and small airways that perform the task of extracting oxygen from the air. Because of this, lung cancer is sometimes called bronchogenic carcinoma - cancer arising from the bronchia. A smaller percentage of lung cancers begin in the pleura - the thin tissue sac that surrounds the lungs. These cancers are called mesothelioma. The most common form of mesothelioma is linked to asbestos exposure.

Cancer of the lungs is one of the deadliest forms of cancer. While it may take a period of years to develop, the cancer often goes undetected until late in the process. In addition, it tends to metastasize (migrate to other parts of the body) early, which leaves fewer opportunities to fight the mutated cells with surgery or radiation. Once the lung cancer does metastasize, it quickly spreads to the most vulnerable and important organs of the body, particularly the adrenal glands, the liver, the brain and the bones.

There are two primary forms of lung cancer - Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC). Small Cell Lung Cancer is less common, though far more deadly. It's directly linked to cigarette smoking - less than 1% of SCLC is diagnosed in non-smokers. It's also extremely aggressive and fast-moving, metastasizing rapidly to other organs, and often undiscovered until it's already widespread.

Non-Small Cell Lung Cancer, on the other hand, is far more common, accounting for nearly 80% of all diagnosed lung cancers. There are three main types of non-small cell lung cancer, generally characterized by the size, shape, and chemical composition of the cells that form the cancer:

Squamous Cell Carcinoma (also referred to as Epidermoid Carcinoma): accounts for around 25% - 30% of all lung cancers, and is associated with a history of smoking. This cancer is nearly always found in the central chest area, near the bronchus.

Adenocarcinoma (also referred to as Bronchioloalveolar Carcinoma): accounts for around 40% of all lung cancers, and is found in the external region of the lung. Treatment for this form of lung cancer often leads to a more successful outcome than that of other lung cancers.

Large-Cell Undifferentiated Carcinoma: accounting for only 10% - 15% of lung cancers, this form may show up in any area of the lung. It tends to spread quickly, and often results in a poor prognosis.

It's also possible for lung cancer to be a combination of Non-Small Cell Lung Cancer types.

There are other, less common types of lung cancer. For instance, bronchial carcinoids are small tumors often found in people under 40 years of age. They tend to grow slowly, and be amenable to treatment. Carcinoid tumors account for approximately 5% of lung tumors. Some are non-cancerous. The others are generally slow-growing and can be successfully treated with surgery.

Finally, some cancers discovered in the lungs aren't lung cancers at all. Since the lungs are prone to metastatic cancers from other sites, it's not uncommon for tumors from other primary cancers to find their way to the lungs. When this occurs, the tumors are often discovered in the peripheral tissues of the lungs rather than in the central tissues.

Please note that the information provided in this article is for information purposes only. It should not be used during a medical emergency or for the diagnosis or treatment of lung cancer. Such situations should always involve the expertise of a physician or health care provider.

About the Author
David Silva is the webmaster for Lung Cancer Insights, a site dedicated to the dissemination of information about lung cancer, mesothelioma, non-small cell lung cancer, and their treatments.

LinkWithin